CONDENSED BALANCE SHEETS (Parenthetical) - USD ($)		Mar. 31, 2021	Dec. 31, 2020
Preferred stock, par value (in dollars per share)		$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)		1,000,000	1,000,000
Preferred stock, shares issued (in shares)		0	0
Preferred stock, shares outstanding (in shares)		0	0
Warrant liabilities	[1]	$ 31,040,535	$ 0
Class A Ordinary Shares Subject To Redemotion
Temporary equity, par value (in dollars per share)		$ 0.0001	$ 0.0001
Temporary equity, shares outstanding (in shares)		93,092,438	0
Temporary equity, shares issued (in dollars per share)		93,092,438	0
Temporary equity, redemption price (in dollars per share)		$ 10.00	$ 10.00
Class A Ordinary Shares
Common stock, par value (in dollars per share)		$ 0.0001	$ 0.0001
Common stock, shares issued (in shares)		6,907,562	0
Common stock, shares outstanding (in shares)		6,907,562	0
Common stock, shares authorized (in shares)		300,000,000	300,000,000
Class B Ordinary Shares
Common stock, par value (in dollars per share)		$ 0.0001	$ 0.0001
Common stock, shares issued (in shares)		25,000,000	25,000,000	[2]
Common stock, shares outstanding (in shares)		25,000,000	25,000,000	[2]
Common stock, shares authorized (in shares)		30,000,000	30,000,000

[1] In April 2021, the Company concluded that, because of a misapplication of the accounting guidance related to its Public and Private Placement warrants, the Company is restating its previously issued balance sheet dated February 4, 2021, filed on Form 8-K on February 10, 2021, in this Quarterly Report. The impact to the balance sheet resulted in a $55.4 million increase to the warrant liabilities line item and offsetting decrease to the Class A ordinary shares subject to possible redemption line item as of February 4, 2021 (see Note 2). Prospectively, the Company will adjust the instruments to fair value at each reporting period and the liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations.

[2] On February 4, 2021, the Company consummated the sale of Over-Allotment Units pursuant to the underwriters’ partial exercise of their over-allotment option. Share amounts as of December 31, 2020 have been retroactively restated to account for the share recapitalization events as discussed in Note 5.